Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.advisorGunn-Moore, Frank J.
dc.contributor.authorBorger, Eva
dc.coverage.spatial349en_US
dc.date.accessioned2012-09-20T20:25:49Z
dc.date.available2012-09-20T20:25:49Z
dc.date.issued2012-06-20
dc.identifieruk.bl.ethos.556410
dc.identifier.urihttp://hdl.handle.net/10023/3092
dc.descriptionElectronic version excludes material for which permission has not been granted by the rights holderen
dc.description.abstractDementia causes an increasing social and economic burden worldwide, demanding action regarding its diagnosis, treatment and everyday management. Recent years have seen many advances in neurodegeneration research, but the search for new truly disease modifying therapies for Alzheimer's disease (AD) and frontotemporal dementia (FTD) has so far not been successful. This is mainly due to a lack of understanding of the precise intracellular events that lead up to neuronal dysfunction in early and in late stages of the disease. This thesis describes the approaches taken to extend the current knowledge about the intracellular effects of neuronal amyloid-beta and the signalling pathways causing neuronal death or disturbed synaptic function in dementia. Endophilin-1(Ep-1), amyloid-binding alcohol dehydrogenase (ABAD), peroxiredoxin-2 (Prx-2) and the EF-hand domain family, member D2 (EFHD2) have been found to be elevated in the human brain with dementia and in mouse models for frontotemporal lobar degeneration (FTLD) or AD. The expression of these proteins as well as the expression of c-Jun N-terminal kinase (JNK), c-Jun and APP were analysed by western blotting and real-time PCR in human brains affected by AD or FTLD as well as in mouse models for AD. This provided a new insight into the regulation of these proteins in relation to each other in the ageing brain and uncovered a new potential link between elevated levels of EFHD2, Prx-2 and APP in FTLD. By studying the effects of the overexpression of Ep-1 in neurons, this research has led to a better understanding of its role in JNK-activation. It furthermore verified a protective role for Prx-2 against neurotoxicity and pointed towards a new function for Prx-2 in the regulation of JNK-signalling. The analysis of the effect of increased levels of EFHD2 uncovered for the first time its involvement in the PI3K-signalling cascade in neuronal cells. The current work has therefore contributed to the knowledge about the cellular processes that are affected by Ep-1, Prx-2 and EFHD2 in different types of dementia and will greatly benefit future research into their actions in the neuronal network.en_US
dc.language.isoenen_US
dc.publisherUniversity of St Andrews
dc.subjectAlzheimer's diseaseen_US
dc.subjectFrontotemporal dementiaen_US
dc.subjectEndophilinen_US
dc.subjectPeroxiredoxinen_US
dc.subjectEFHD2en_US
dc.subjectC-Jun N-tmerinal kinaseen_US
dc.subject.lccQP552.A45B7
dc.subject.lcshAlzheimer's disease--Molecular aspectsen_US
dc.subject.lcshPresenile dementiaen_US
dc.subject.lcshAmyloid beta-proteinen_US
dc.subject.lcshCellular signal transductionen_US
dc.titleNew intracellular mechanisms involved in Alzheimer's disease and frontotemporal dementiaen_US
dc.typeThesisen_US
dc.type.qualificationlevelDoctoralen_US
dc.type.qualificationnamePhD Doctor of Philosophyen_US
dc.publisher.institutionThe University of St Andrewsen_US


This item appears in the following Collection(s)

Show simple item record